[2P-0578] The comparison between human mesenchymal stem cells from different sources for oncolytic viral therapy

^○Makoto Sukegawa^{1, 2, 3}, Yoshitaka Miyagawa¹, Seiji Kuroda¹, Motoko Yamamoto¹, Kumi Adachi¹, Nobuhiko Taniai², Hiroshi Yoshida³, Akihiro Umezawa⁴, Mashito Sakai¹, Takashi Okada⁵ (1.Dept. of Biochem., Mol. Biol., Nippon Medical School, 2.Dept. of Gastrointestinal Surg., Nippon Medical School Musashikosugi Hospital, 3.Dept. of Surg., Nippon Medical School, 4.Cent. for Regenerative Med., National Center for Child Health and Development Research Institute, 5.Div. of Mol. and Med. Genetics, Center for Gene and Cell Therapy, The Institute of Med. Sci., The Univ. of Tokyo)

The 44th Annual Meeting of the Molecular Biology Society of Japan

[2P-0579] Analysis of the anti-metastatic microenvironment in the lung induced by the primary tumor

^○Shigeaki Sugiyama¹, Kanae Yumimoto¹, Kei Takahashi², Shimpei Kubota³, Kohei Miyazono⁴, Keiichi Nakayama¹ (1.Dept. of Mol. and Cell. Bio., Univ. of Kyushu, 2.Dept. of Chem., Fac. of Sci., Univ. of Alberta, 3.Dept. of Mol. Neuroimmunology, Univ. of Hokkaido, 4.Dept. of Mol. Pathology, Grad. Sch. of Med., Univ. of Tokyo)

The 44th Annual Meeting of the Molecular Biology Society of Japan

[2P-0580] DNA methylation marker to estimate cancer cell fraction

^○Takahiro Ebata¹, Satoshi Yamashita¹, Hideyuki Takeshima¹, Hiroshi Yoshida², Kan Yonemori³, Tomoyasu Kato⁴, Toshikazu Ushijima¹ (1.Div. Epigenomics, Natl. Cancer Ctr. Res. Inst., 2.Dept. of Diagnostic Pathology , Natl. Cancer Ctr. hosp., 3.Dept. of Medical Oncology, Natl. Cancer Ctr. hosp., 4.Dept. of Gynecology, Natl. Cancer Ctr. hosp.)

The 44th Annual Meeting of the Molecular Biology Society of Japan

[2P-0581] Identification and characterization of lymphangioleiomyomatosis cells by single-cell RNA sequencing

^○Riichiroh Manabe¹, Yasuhito Sekimoto², Nozomi Moritsugu¹, Yoichiro Mitsuishi², Norihito Hayatsu¹, Hiroko Kinoshita¹, Shohei Noma¹, Tomoko Hirata¹, Chitose Takahashi¹, Michihira Tagami¹, Yasushi Okazaki¹, Kuniaki Seyama² (1.Lab. for Comprehensive Genomic Analysis, IMS, RIKEN, 2.Dept. of Respir. Med., Grad. Sch. of Med. Juntendo Univ.)

The 44th Annual Meeting of the Molecular Biology Society of Japan

[2P-0582] Development of cancer-targeting molecules labeled with alpha-emitting radionuclides and their application to cancer immunotherapy

^○Koki Mayusumi¹, Kazuya Kabayama^{1, 2, 3}, Changhao Dai¹, Kazuko Kaneda^{2, 3}, Kazuhiro Ooe^{2, 3, 4}, Takahiro Teramoto^{2, 3}, Atsushi Toyoshima^{2, 3}, Atsushi Shinohara^{2, 3}, Koichi Fukase^{1, 2, 3} (1.Dept. of Chem. Sci., Grad. Sch. of Sci., Osaka Univ., 2.PRC, Grad. Sch. of Sci., Osaka Univ., 3.Inst. for Radiation Sciences, Osaka Univ., 4.Grad. Sch. of Med., Osaka Univ.)

The 44th Annual Meeting of the Molecular Biology Society of Japan

[2P-0583] Development of CAR-T cells that recognize PRAMEp301-309/HLA-A2402 complex

^○Hiroyuki Hiratsuka¹, Yasushi Akahori¹, Kazuko Shirakura¹, Takuma Kato², Hiroshi Shiku¹ (1.Dept. Personalized Can. Immuno., Grad. Sch. Med., Mie Univ., 2.Dept. Immuno., Grad. Sch. Med., Mie Univ.)

The 44th Annual Meeting of the Molecular Biology Society of Japan

[2P-0584] Efficacy of HDAC Inhibitors in lung adenocarcinoma

^○Yuma Shindo^{1, 2}, Wataru Arai^{1, 2}, Takumi Konno¹, Takayuki Kohno¹, Atsushi Watanabe², Takashi Kojima¹ (1.Department of Cell Science, Research Institute for Frontier Medicine, Sapporo Medical University School of Medicine, 2.Department of Thoracic Surgery, Sapporo Medical University School of Medicine)

The 44th Annual Meeting of the Molecular Biology Society of Japan

[2P-0585] Functional analysis of neo-substrates for the thalidomide target protein CRBN

^○Tetsuo Nagase, Yuki Yamaguchi, Junichi Yamamoto (Dept. of Life. Sci. Tech., Sch. of Life. Sci. Tech.,Tokyo Tech)

The 44th Annual Meeting of the Molecular Biology Society of Japan

[2P-0586] Effectiveness verification of SNPD-siPIK3CA that specifically represses the expression of oncogenic PIK3CA gene with single nucleotide mutation

^○Toshinori Ohyama¹, Yoshiaki Kobayashi², Kumiko UiTei² (1.Dept. of Comp. Biol. and Med. Sci., Grad. Sch. of Frontier Sci., Univ. of Tokyo, 2.Dept. of Biol. Sci., Grad. Sch. of Sci., Univ. of Tokyo)

The 44th Annual Meeting of the Molecular Biology Society of Japan

[2P-0587] RIG-I pathway regulates radiotherapy-induced immune response in cancer cells

^○Junyan Du^{1, 2}, Riu Yamashita^{1, 2}, Yumi Hakozaki³, Ohashi Akihiro⁴, Tomoko Morita⁴, Kosuke Tanaka⁴, Katsuya Tsuchihara^{1, 2}, Shunichiro Kageyama³ (1.Grad. Sch. of Frontier Sci., Univ. of Tokyo, 2.Div. of Translational Informatics, EPOC, Natl.Cancer Ctr., 3.Div. of Radiation Oncology and Particle Therapy, EPOC, Natl.Cancer Ctr., 4.Div. of Translational Genomics, EPOC, Natl.Cancer Ctr.)

The 44th Annual Meeting of the Molecular Biology Society of Japan